NCT06499350 2026-03-10
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase 1/2 Recruiting
Clinical Trials
23 trialsNCT06573294 2026-03-03
Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors
Genmab
Phase 1 Recruiting
NCT07292402 2025-12-23
JSKN022 in Subjects With Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1 Recruiting
NCT06231550 2025-08-07
A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase 1 Completed
NCT05383703 2025-07-02
MNC-168
Moon (Guangzhou) Biotechnology Co., Ltd.
Phase 1 Completed
NCT06464055 2025-02-10
A Study of GQ1010 in Subjects With Advanced Solid Tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Phase 1/2 Recruiting
NCT04908046 2024-10-15
A Study of HMPL-295S1 in Patients With Advanced Malignant Solid Tumors
Hutchmed
Phase 1 Completed
NCT05773937 2024-09-19
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1 Recruiting
NCT05886374 2023-07-21
A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors
Hutchmed
Phase 1 Recruiting
NCT05949775 2023-07-18
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Stemirna Therapeutics
Phase NA Not yet recruiting
NCT05338957 2022-12-01
A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.
Shanghai Miracogen Inc.
Phase 1/2 Unknown
NCT03792958 2022-11-14
Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors
AnewPharma
Phase 1 Unknown
NCT05478785 2022-07-29
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1/2 Unknown
NCT05277454 2022-03-14
Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT
Hutchmed
Phase 1 Unknown
NCT04328506 2021-11-26
Bioequivalency Study of CM082 Tablet in Healthy Volunteers
AnewPharma
Phase 1 Completed
NCT04226066 2020-12-07
Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors
Tasly Tianjin Biopharmaceutical Co., Ltd.
Phase 1/2 Unknown
NCT04126668 2020-05-21
A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers
AnewPharma
Phase 1 Completed
NCT02045095 2019-03-14
A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors
Takeda
Phase 1 Terminated
NCT01128842 2018-12-19
A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor
Puma Biotechnology, Inc.
Phase 1 Completed
NCT00768469 2018-11-19
Study Evaluating Safety And Tolerability, Solid Tumor
Puma Biotechnology, Inc.
Phase 1 Completed
NCT00997360 2018-09-27
Study of PKI-179 Administered Orally to Subjects With Solid Tumors
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Withdrawn
NCT00958724 2018-06-28
Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors
Puma Biotechnology, Inc.
Phase 1 Completed
NCT00728468 2017-08-02
A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients
Pfizer
Phase 1 Completed